2174. Cefiderocol Activity Against Multidrug-resistant and Molecularly Characterized Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus complex Clinical Isolates Causing Infection in United States Hospitals (2020–2022)

BACKGROUND: Cefiderocol (CFDC) is a siderophore-conjugated cephalosporin with activity against Gram-negative bacteria. CFDC and comparator activities were evaluated against resistant and molecularly characterized P. aeruginosa (PSA) and A. baumannii-calcoaceticus complex (ABC) as part of the SENTRY...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Hubler, Cory, Kantro, Valerie, Shortridge, Dee, Sader, Helio S, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678725/
http://dx.doi.org/10.1093/ofid/ofad500.1796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678725/
http://dx.doi.org/10.1093/ofid/ofad500.1796

Ejemplares similares